Edgewise Therapeutics, Inc. (EWTX) vs Heartflow, Inc. Common Stock (HTFL)

A side-by-side comparison of Edgewise Therapeutics, Inc. and Heartflow, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Edgewise Therapeutics, Inc. logo
EWTX
Edgewise Therapeutics, Inc.
$4.26B
$39.64HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Heartflow, Inc. Common Stock logo
HTFL
Heartflow, Inc. Common Stock
$4.42B
$51.25HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT

Total return — EWTX vs HTFL

growth of $100 · dividends reinvested · last 1y
EWTX +211.2% (+211.2%/yr)HTFL +81.6% (+81.6%/yr)EWTX compounded faster over this window
100200300Start $1002026$311$182
EWTX HTFL

EWTX vs HTFL: by the numbers

  • •HTFL is the larger company ($4.42B vs $4.26B market cap).
  • •Both run net losses; EWTX's is the smaller (0.00% vs -55.82% net margin).

Metrics side by side

Valuation

MetricEWTXHTFL
P/S ratioN/A20.84
P/B ratio9.5215.80

Profitability

MetricEWTXHTFL
Gross margin0.00%80.08%
Operating margin0.00%-34.31%
Net margin0.00%-55.82%
ROE-44.02%-42.32%
ROIC-48.57%-23.69%

Growth (annualized)

MetricEWTXHTFL
Total return CAGR (5Y)16.95%N/A

Go deeper

Full EWTX analysisFull HTFL analysisInteractive comparison tool

Dig into the metrics

Edgewise Therapeutics ROEHeartflow, Inc. Common Stock ROEEdgewise Therapeutics operating marginHeartflow, Inc. Common Stock operating marginEdgewise Therapeutics revenue growthHeartflow, Inc. Common Stock revenue growthEdgewise Therapeutics free cash flowHeartflow, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.